S57L (p.Ser57Leu) variant of IRS1 (Insulin receptor substrate 1)
S57L (p.Ser57Leu) in IRS1 (Insulin receptor substrate 1) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact.
S57L (p.Ser57Leu) variant details
- p.Ser57Leu
- NCI-TCGA TCGA novel
- TOPMed rs1294206506
- gnomAD rs1294206506
- Variant assessed as somatic; moderate impact.
- Missense
- UniProt: Variant assessed as somatic; moderate impact.